文献速递其他结缔组织病

抗Ku综合征伴CK升高与伴抗dsDNA抗体是两种结局不同的独立疾病实体

Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes.
PubMed 文献 · Ann Rheum Dis · 2019-05-24

该研究对42例连续抗Ku抗体阳性患者进行层次聚类分析,依据随访期间累积的临床生物学特征划分亚组,发现抗Ku相关疾病可聚为三类,其中基线CK升高与抗dsDNA抗体互斥,分别预测不同预后:CK升高者间质性肺病风险高22倍,抗dsDNA阳性者肾小球肾炎风险高13倍。

要点

  • 抗Ku抗体阳性患者可聚类为三个临床生物学特征不同的亚组。
  • 基线CK升高与抗dsDNA抗体互斥,可预测随访终点的亚组归属。
  • 抗Ku伴CK升高者间质性肺病风险高22倍,抗dsDNA阳性者肾小球肾炎风险高13倍。

核心结论

  • 抗Ku伴CK升高综合征与抗Ku伴抗dsDNA综合征是两种需识别的独立疾病实体,以指导个体化诊疗。

研究设计与样本

  • 研究纳入42例连续抗Ku抗体阳性患者,采用层次聚类分析累积临床生物学特征以划分亚组,并用敏感度-特异度总和最大化方法识别预测结局的基线特征。

主要发现

  • 临床生物学特征聚为三组,肾小球肾炎和间质性肺病两种致死性并发症在三组间分布不均,且三组在六项临床生物学特征上存在差异。
  • 基线CK升高与抗dsDNA抗体通常互斥,且最能有效预测随访终点的聚类归属。
  • 抗Ku伴CK升高患者发生间质性肺病的风险高22倍,抗Ku伴抗dsDNA抗体患者发生肾小球肾炎的风险高13倍。

关键数值与推荐

  • 抗Ku伴CK升高者间质性肺病风险高22倍;抗Ku伴抗dsDNA抗体者肾小球肾炎风险高13倍。

临床怎么用

  • 对抗Ku抗体阳性患者,应检测基线CK和抗dsDNA抗体以区分两种综合征,CK升高者警惕间质性肺病,抗dsDNA阳性者警惕肾小球肾炎,从而制定个体化监测与治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To refine the spectrum of anti-Ku-associated disease, a condition that is equivocally described by current diagnostic criteria for connective tissue diseases. METHODS: Among 42 consecutive patients harbouring anti-Ku antibodies, subgroups with similar phenotypes and prognosis were delineated without an a priori diagnosis using hierarchical clustering analysis of the cumulative clinico-biological features recorded during the follow-up. Features present at baseline that most efficiently predicted the outcomes were then identified using a sensitivity-specificity sum maximisation approach. RESULTS: Clinico-biological features were clustered into three groups. Glomerulonephritis and ILD, the two fatal complications in this cohort, were unequally distributed between the three clusters that additionally differed on six clinico-biological features.Among features present at baseline, elevated serum level of creatine kinase (CK) and anti-dsDNA antibodies were generally mutually exclusive and most efficiently predicted the cluster belonging at last follow-up. Anti-Ku patients with elevated CK had a 22-fold higher risk of ILD while anti-Ku patients with anti-dsDNA antibodies had a 13-fold higher risk of glomerulonephritis CONCLUSION: "Anti-Ku with elevated CK" syndrome and "anti-Ku with anti-dsDNA" syndrome represent two distinct entities that are important to recognise in order to best tailor patient care.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Spielmann L, Nespola B, Séverac F, et al. Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes. Ann Rheum Dis. 2019. PMID: 31126956. doi:10.1136/annrheumdis-2018-214439

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。